Table 1. Correlation of the Expression Level of miR-181a in OC Tissues and CTCs with Other Clinical Features (x + s).
OC tissue |
CTCs |
|||||
---|---|---|---|---|---|---|
clinical features | n | ΔCt | P | n | ΔCt | P |
age | 0.993 | 1.052 | ||||
≥60 | 11 | –2.933 ± 2.199 | 17 | –2.947 ± 2.109 | ||
<60 | 19 | –3.025 ± 2.209 | 13 | –2.899 ± 2.119 | ||
history of diabetes | 1.105 | 0.987 | ||||
yes | 3 | –3.288 ± 2.406 | 5 | –3.149 ± 2.525 | ||
no | 17 | –3.682 ± 2.025 | 15 | –3.801 ± ± 2.525 | ||
FIGO stage | 0.013 | 0.046 | ||||
stage I+ II | 20 | –2.926 ± 2.209 | 15 | –3.139 ± 2.415 | ||
stage III + IV | 10 | –5.156 ± 2.005 | 15 | –5.936 ± 2.215 | ||
histological grade | 0.516 | 0.725 | ||||
G1 | 22 | –3.149 ± 2.525 | ||||
G2+G3 | 8 | –3.801 ± 2.525 | ||||
lymphatic metastasis | 0.024 | 0.016 | ||||
no | 25 | –3.182 ± 2.369 | 6 | –2.193 ± 2.233 | ||
yes | 5 | –4.812 ± 2.401 | 24 | –4.926 ± 2.045 | ||
myometrial infiltration | 1.033 | 0.991 | ||||
≤1/2 | 27 | –3.088 ± 2.406 | 23 | –3.112 ± 2.233 | ||
>1/2 | 3 | –4.682 ± 2.025 | 7 | –3.139 ± 2.125 |